Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

Overview

About this study

Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist providers in improving screening and preventative options.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: -Women participating in IRB:18-010601 -Aged 35 and over with a negative routine mammogram within 3 months. -Qualifies as intermediate or high-risk (>15% lifetime risk of breast cancer as defined by IBIS version 8). -Have an active email address for survey completion Exclusion Criteria: -Not participating in the Mayo Clinic CEDM pilot (IRB: 18-010601) -Known genetic cancer syndrome with test results available for review in Mayo EMR -Known breast cancer -Unable to understand or sign informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Niloy Jewel Samadder, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Niloy Jewel Samadder, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials